Jeanmonod Patrik has filed 43 insider transactions across 1 company since September 2022.
Most recent transaction: a option exercise of 4908 shares of Cytek Biosciences, Inc. ($CTKB) on March 11, 2024.
Activity breakdown: 0 open-market purchases and 12 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2024 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | CHIEF FINANCIAL OFFICER | M | Common Stock | 4908 | $0.00 | 99,377.0000 | 135,283,044 | 5.20% | 0.00% |
| March 11, 2024 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | CHIEF FINANCIAL OFFICER | F | Common Stock | 1912 | $7.22 | 97,465.0000 | 135,283,044 | 1.92% | 0.00% |
| March 11, 2024 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 4908 | $0.00 | 44,182.0000 | 135,283,044 | 10.00% | 0.00% |
| Feb. 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | CHIEF FINANCIAL OFFICER | M | Common Stock | 1752 | $0.00 | 95,152.0000 | 135,283,044 | 1.88% | 0.00% |
| Feb. 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | CHIEF FINANCIAL OFFICER | F | Common Stock | 683 | $8.38 | 94,469.0000 | 135,283,044 | 0.72% | 0.00% |
| Feb. 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 1752 | $0.00 | 13,442.0000 | 135,283,044 | 11.53% | 0.00% |
| Dec. 26, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | S | Common Stock | 3000 | $9.50 | 93,400.0000 | 138,562,111 | 3.11% | 0.00% |
| Nov. 24, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | S | Common Stock | 3000 | $6.94 | 96,400.0000 | 138,562,111 | 3.02% | 0.00% |
| Nov. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Common Stock | 1752 | $0.00 | 97,836.0000 | 138,562,111 | 1.82% | 0.00% |
| Nov. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | F | Common Stock | 683 | $5.98 | 97,153.0000 | 138,562,111 | 0.70% | 0.00% |
| Nov. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Common Stock | 3681 | $0.00 | 100,834.0000 | 138,562,111 | 3.79% | 0.00% |
| Nov. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | F | Common Stock | 1434 | $5.98 | 99,400.0000 | 138,562,111 | 1.42% | 0.00% |
| Nov. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Restricted Stock Units | 1752 | $0.00 | 15,194.0000 | 138,562,111 | 10.34% | 0.00% |
| Nov. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Restricted Stock Units | 3681 | $0.00 | 49,090.0000 | 138,562,111 | 6.98% | 0.00% |
| Oct. 24, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | S | Common Stock | 3000 | $4.68 | 96,084.0000 | 138,562,111 | 3.03% | 0.00% |
| Sept. 25, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | S | Common Stock | 3000 | $6.38 | 99,084.0000 | 138,562,111 | 2.94% | 0.00% |
| Aug. 24, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | S | Common Stock | 3000 | $7.69 | 102,084.0000 | 138,562,111 | 2.85% | 0.00% |
| Aug. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Common Stock | 1752 | $0.00 | 103,520.0000 | 138,562,111 | 1.72% | 0.00% |
| Aug. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | F | Common Stock | 683 | $8.46 | 102,837.0000 | 138,562,111 | 0.66% | 0.00% |
| Aug. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Common Stock | 3681 | $0.00 | 106,518.0000 | 138,562,111 | 3.58% | 0.00% |
| Aug. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | F | Common Stock | 1434 | $8.46 | 105,084.0000 | 138,562,111 | 1.35% | 0.00% |
| Aug. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Restricted Stock Units | 1752 | $0.00 | 16,946.0000 | 138,562,111 | 9.37% | 0.00% |
| Aug. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Restricted Stock Units | 3681 | $0.00 | 52,771.0000 | 138,562,111 | 6.52% | 0.00% |
| July 24, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | S | Common Stock | 3000 | $9.17 | 101,768.0000 | 138,562,111 | 3.04% | 0.00% |
| June 26, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | S | Common Stock | 3000 | $7.96 | 104,768.0000 | 138,562,111 | 2.78% | 0.00% |
| May 24, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | S | Common Stock | 3000 | $7.76 | 107,768.0000 | 138,562,111 | 2.71% | 0.00% |
| May 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Common Stock | 1752 | $0.00 | 109,953.0000 | 138,562,111 | 1.62% | 0.00% |
| May 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | F | Common Stock | 683 | $6.69 | 109,270.0000 | 138,562,111 | 0.62% | 0.00% |
| May 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Common Stock | 2454 | $0.00 | 111,724.0000 | 138,562,111 | 2.25% | 0.00% |
| May 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | F | Common Stock | 956 | $6.69 | 110,768.0000 | 138,562,111 | 0.86% | 0.00% |
| May 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Restricted Stock Units | 1752 | $0.00 | 18,698.0000 | 138,562,111 | 8.57% | 0.00% |
| May 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Restricted Stock Units | 2454 | $0.00 | 56,452.0000 | 138,562,111 | 4.17% | 0.00% |
| April 24, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | S | Common Stock | 3000 | $10.24 | 108,201.0000 | 138,562,111 | 2.70% | 0.00% |
| March 24, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | S | Common Stock | 3000 | $8.33 | 111,201.0000 | 138,562,111 | 2.63% | 0.00% |
| March 3, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 89031 | $0.00 | 89,031.0000 | 138,562,111 | 9999.99% | 0.06% |
| March 3, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | A | Restricted Stock Units | 58906 | $0.00 | 58,906.0000 | 138,562,111 | 9999.99% | 0.04% |
| Feb. 24, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | S | Common Stock | 3000 | $11.05 | 114,201.0000 | 138,562,111 | 2.56% | 0.00% |
| Feb. 21, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Common Stock | 1752 | $0.00 | 117,884.0000 | 138,562,111 | 1.51% | 0.00% |
| Feb. 21, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | F | Common Stock | 683 | $10.97 | 117,201.0000 | 138,562,111 | 0.58% | 0.00% |
| Feb. 21, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Restricted Stock Units | 1752 | $0.00 | 20,450.0000 | 138,562,111 | 7.89% | 0.00% |
| Sept. 8, 2022 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Common Stock | 40000 | $0.40 | 116,132.0000 | 0 | 52.54% | 0.00% |
| Sept. 8, 2022 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | M | Employee Stock Option (Right to Buy) | 40000 | $0.00 | 202,661.0000 | 0 | 16.48% | 0.00% |
| Jan. 24, 2023 | Cytek Biosciences, Inc. | $CTKB | Jeanmonod Patrik | Chief Financial Officer | S | Common Stock | 3500 | $11.05 | 76,132.0000 | 138,562,111 | 4.40% | 0.00% |